|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 17.75 | ACUITE B+ | Downgraded | Issuer not co-operating* | - |
Bank Loan Ratings | 16.25 | - | ACUITE A4 | Downgraded | Issuer not co-operating* |
Total Outstanding | 34.00 | - | - |
Rating Rationale |
Acuité has downgraded the long-term rating to 'ACUITE B+' (read as ACUITE B plus) from ‘ACUITE BB-’ (read as ACUITE double B minus) and the short term rating to 'ACUITE A4' (read as ACUITE A four) from ‘ACUITE A4+’ (read as ACUITE A four plus) on the Rs. 34.00 crore bank facilities of Abhilash Chemicals and Pharmaceutical Private Limited (ACPPL). The rating continues to be flagged as “Issuer Not-Cooperating” and is downgraded on account of information risk. |
About the Company |
Abhilash Chemicals and Pharmaceuticals Private Limited, is a Tamil Nadu based company incorporated in the year 1994. The company is engaged in manufacturing of pharmaceutical raw materials (API), Specialty chemicals. The company’s manufacturing facility is located at Madurai, Tamil Nadu with an installed capacity of 300 tons per month for pharma division (API), 300 tons per month for Leather Chemical Division and 100 tons per month for Resins. The products manufactured by the company are used for Diabetic Formulation Industries, Leather Manufacturers and Ink/Paint Industries. It is directed by Mr. Lakshminarayan Iyer. |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies. |
Limitation regarding information availability: |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavored to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based. |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
Operating Income | Rs. Cr. | 128.87 | 113.30 |
PAT | Rs. Cr. | 7.56 | 8.67 |
PAT Margin | (%) | 5.87 | 7.65 |
Total Debt/Tangible Net Worth | Times | 0.41 | 0.48 |
PBDIT/Interest | Times | 7.08 | 7.05 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on Complexity Levels of the Rated Instrument |
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in. |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
Contacts |
|
|
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |